Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

is a clinically common opportunistic pathogen that causes pneumonia and upper respiratory tract infection in humans as well as community-and hospital-acquired infections, posing significant threats to public health. Moreover, the insertion of a plasmid carrying the mobile colistin resistance (MCR) genes brings obstacles to the clinical treatment of infection. In this study, a strain of colistin-resistant (CRKP) was isolated from sputum samples of a patient who was admitted to a tertiary hospital in Tai'an city, China, and tested for drug sensitivity. The results showed that KPTA-2108 was multidrug-resistant (MDR), being resistant to 21 of 26 selected antibiotics, such as cefazolin, amikacin, tigecycline and colistin but sensitive to carbapenems via antibiotic resistance assays. The chromosome and plasmid sequences of the isolated strain KPTA-2108 were obtained using whole-genome sequencing technology and then were analyzed deeply using bioinformatics methods. The whole-genome sequencing analysis showed that the length of KPTA-2108 was 5,306,347 bp and carried four plasmids, pMJ4-1, pMJ4-2, pMJ4-3, and pMJ4-4-MCR. The plasmid pMJ4-4-MCR contained 30,124 bp and was found to be an IncX4 type. It was the smallest plasmid in the KPTA-2108 strain and carried only one resistance gene . Successful conjugation tests demonstrated that pMJ4-4-MCR carrying could be horizontally transmitted through conjugation between bacteria. In conclusion, the acquisition and genome-wide characterization of a clinical MDR strain of CRKP may provide a scientific basis for the treatment of infection and epidemiological data for the surveillance of CRKP.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963795PMC
http://dx.doi.org/10.3390/pathogens12020221DOI Listing

Publication Analysis

Top Keywords

tai'an city
8
city china
8
treatment infection
8
whole-genome sequencing
8
genomic characteristics
4
characteristics phylogenetic
4
phylogenetic analyses
4
analyses multiple
4
multiple drug-resistant
4
drug-resistant harboring
4

Similar Publications

While the global dissemination of extended-spectrum β-lactamases (ESBLs) in clinical isolates from various animals is well-documented, research on Klebsiella pneumoniae in Trichomonas gallinae-infected pigeons, particularly concerning antibiotic resistance genes in China, remains limited. This study aimed to investigate the relationship between oral harmful microbiota in pigeons and T. gallinae infection, as well as to isolate K.

View Article and Find Full Text PDF

Assessing the Prognostic Accuracy of the PSS, pSOFA, and SIRS for In-Hospital Mortality in Children with Suspected Infection in Non-ICU Settings: A Multicenter Retrospective Study.

Int J Infect Dis

September 2025

Department of Clinical Laboratory, Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health National Children's Regional Medical Center, Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, 311121, China. Electronic address: qingye

Objectives: To systematically compare the predictive accuracy of the Phoenix Sepsis Score (PSS), the Pediatric Sequential Organ Failure Assessment (pSOFA), and systemic inflammatory response syndrome (SIRS) in assessing in-hospital mortality risk among pediatric sepsis patients in non-ICU wards, thereby providing evidence-based support for clinical risk stratification.

Design: This study employed a multicenter retrospective cohort design, enrolling non-ICU pediatric patients with suspected infections (excluding preterm infants and neonates hospitalized immediately after birth), to construct an overall cohort and a neonatal subgroup cohort. Clinical parameters were collected through a data acquisition system, with parallel calculations of PSS, pSOFA, and SIRS scores.

View Article and Find Full Text PDF

A disproportionality analysis of real-world adverse events associated with tirofiban from the FAERS database.

Sci Rep

September 2025

Institute of Cardiovascular Diseases & Department of Cardiology, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610072, China.

Tirofiban is a glycoprotein IIb/IIIa receptor blocker mainly used alongside other blood thinners in patients with acute coronary syndrome (ACS) undergoing procedures like angioplasty (PCI). Emerging clinical evidence suggests it may also be beneficial during endovascular treatment for ischemic stroke (IS). Because Tirofiban prevents blood clotting, it is important to assess how often it causes serious bleeding or other side effects when used in real-life settings.

View Article and Find Full Text PDF

The science and technology innovation board (STIB) is a critical initiative to support the high-quality development of technology innovation enterprises. Accurate valuation of STIB-listed enterprises is essential for optimizing resource allocation and enhancing capital market efficiency. However, existing valuation methods face significant challenges, including the presence of nonlinear data and low accuracy when assessing these enterprises.

View Article and Find Full Text PDF